Tracheloside exhibits significant anti-inflammatory and analgesic properties, making it valuable in the development of natural-based pharmaceuticals for pain relief and inflammation control. It has been studied for its ability to modulate key inflammatory pathways, including the inhibition of pro-inflammatory cytokines and enzymes such as COX-2 and LOX. Due to its natural origin and bioactivity, tracheloside is also explored as a lead compound in designing derivatives for improved therapeutic efficacy. Additionally, it shows potential in dermatological applications, where its anti-inflammatory effects can be harnessed in topical formulations for skin conditions like dermatitis and irritation. Research is ongoing into its antioxidant activity, which may support its use in protective agents against oxidative stress-related disorders.